Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer

Oncology Letters

Volumn 2, Issue 5, 2011, Pages 995-1001

  Tao, Yajun ^a   Mao, Jun ^b   Zhang, Qingqing ^b   Li, Lianhong ^b  

^a DALIAN UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; Glioma associated oncogene homoglog 1; Patched 1; Smoothened; Sonic Hedgehog; Triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN PATCHED 1; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER;

EID: 79960287553     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.357     Document Type: Article

References (33)

1. Köster F, Engel JB, Schally AV, et al: Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition. Breast Cancer Res Treat 116: 273-279, 2009.
2. Carey LA, Dees EC, Sawyer L, et al: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13: 2329-2334, 2007.
3. Sotiriou C, Phil D and Pusztaj J: Gene-expression signatures in breast cancer. N Engl J Med 360: 790-800, 2009.
4. Liedtke C, Mazouni C, Hess KR, et al: Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26: 1275-1281, 2008.
5. De Ruijter TC, Veeck J, de Hoon JPJ, van Engeland M and Tjan-Heijnen VC: Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137: 183-192, 2011.
6. Rakha EA, Elsheikh SE, Aleskandarany MA, et al: Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15: 2302-2310, 2009.
7. Lim KH, Oh DY, Chie EY, et al: Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity. Jpn J Clin Oncol 40: 112-118, 2010.
8. Tischkowitz M, Brunet JS, Bégin LR, Huntsman DG, Cheang MC, Akslen LA, Nielsen TO and Foulkes WD: Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer 7: 134, 2007.
9. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A and Winer EP: Sites of distant relapse and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 113: 2638-2645, 2008.
10. Chacón RD and Costanzo MV: Triple-negative breast cancer. Breast Cancer Res 12 (Suppl 2): 3, 2010.
11. Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Symmans WF, Pusztai L and Hortobagyi GN: Targeted therapy in breast cancer:the HER-2/neu gene and protein. Mol Cell Proteomics 3: 379-398, 2004.
12. Zhang XM, Harrington N, Moraes RC, Wu MF, Hilsenbeck SG and Lewis MT: Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo). Breast Cancer Res Treat 115: 505-521, 2009.
13. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH Jr and Scott MP: Basal cell carcinomas in mice overexpressing sonic Hedgehog. Science 276: 817-821, 1997.
14. Han ME, Lee YS, Baek SY, Kim BS, Kim JB and Oh SO: Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of Bcl-2. Int J Mol Sci 10: 3033-3043, 2009.
15. Dormoy V, Danilin S, Lindner V, et al: The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer 8: 123, 2009.
16. Chen M, Tanner M, Levine AC, Levina E, Ohouo P and Buttyan R: Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle 8: 149-157, 2009.
17. Liu S, Dontu G and Wicha MS: Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 7: 86-95, 2005.
18. Zhou JX, Jia LW, Liu WM, Miao CL, Liu S, Cao YJ and Duan EK: Role of sonic hedgehog in maintaining a pool of proliferating stem cells in the human fetal epidermis. Hum Reprod 21: 1698-1704, 2006.
19. Kasper M, Jaks V, Fiaschi M and Toftgård R: Hedgehog signaling in breast cancer. Carcinogenesis 30: 903-911, 2009.
20. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071, 2006.
21. Singletary SE and Connolly JL: Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 56: 37-47, 2006.
22. Sinicrope FA, Ruan SB, Cleary KB, Stephens LC, Lee JJ and Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241, 1995.
23. Ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R and Dahl E: Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer 9: 298-309, 2009.
24. Pan S, Dong Q, Sun LS and Li TJ: Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modifica- tion of the two-hit hypothesis. Clin Cancer Res 16: 442-450, 2010.
25. Yauch RL, Dijkgraaf GJ, Alicke B, et al: Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326: 572-574, 2009.
26. Epstein EH: Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 8: 743-754, 2008.
27. Peacock CD, Wang Q, Gesell GS, et al: Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 104: 4048-4053, 2007.
28. Moraes RC, Zhang X, Harrington N, Fung JY, Wu MF, Hilsenbeck SG, Allred DC and Lewis MT: Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 134: 1231-1242, 2007.
29. Gao J, Graves S, Koch U, Liu S, et al: Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 4: 548-558, 2009.
30. Zhao C, Chen A, Jamieson CH, et al: Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458: 776-779, 2009.
31. Zardawi SJ, O'Toole SA, Sutherland RL and Musgrove EA: Dysregulation of Hedgehog, Wnt and Notch signaling pathways in breast cancer. Histol Histopathol 24: 385-398, 2009.
32. Zhao J, Chen G, Cao D, Li Y, Diao F, Cai H, Jin Y and Lu J: Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth. Breast Cancer Res Treat 119: 39-51, 2010.
33. Boman BM and Wicha MS: Cancer stem cells: a step toward the cure. J Clin Oncol 26: 2795-2799, 2008.